Researcher
Matteo Riva
- Disciplines:Oncology, Immunology
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Jun 2019 → Today - Department of Microbiology, Immunology and Transplantation (Department)
Member
From1 May 2016 → 31 Oct 2019
Projects
1 - 2 of 2
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization and analysis of in vivo intracranial models for glioblastomaFrom1 Dec 2019 → 31 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 31
- CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI(2021)
Authors: Liesbeth Vanherp, Matteo Riva, An Coosemans, Katrien Lagrou, Willy Gsell, Greetje Vande Velde, Uwe Himmelreich
Number of pages: 11 - Type of chemotherapy has substantial effects on the immune system in ovarian cancer(2021)
Authors: Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Jolien Ceusters, Ignace Vergote, An Coosemans
Number of pages: 8 - Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma(2021)
Authors: Matteo Riva, Roxanne Wouters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: E205 - E215Number of pages: 11 - Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma(2021)
Authors: Roxanne Wouters, Sien Bevers, Matteo Riva, Frederik De Smet, An Coosemans
Number of pages: 24 - Long-lived tumor-associated macrophages in glioma.(2020)
Authors: Matteo Riva, Holger Gerhardt
Pages: vdaa127 - Immune-driven therapeutic combinations in a new mouse model of high-grade glioma(2019)
Authors: Matteo Riva, An Coosemans, Marc Van Ranst
- CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression(2019)
Authors: Matteo Riva, Roxanne Wouters, Sarah Belderbos, David Nittner, Dietmar Rudolf Thal, Thaïs Baert, Willy Gsell, Uwe Himmelreich, Marc Van Ranst, An Coosemans
Number of pages: 13 - Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer(2019)
Authors: Thaïs Baert, Ann Vankerckhoven, Matteo Riva, Ignace Vergote, An Coosemans
Number of pages: 13 - Combining conventional therapy with immunotherapy: A risky business?(2019)
Authors: An Coosemans, Ann Vankerckhoven, Thaïs Baert, Louis Boon, Hanne Ruts, Matteo Riva, Sarah Blagden, Michel Delforge, Nicole Concin, Mansoor Mirza, et al.
Pages: 41 - 44 - Combining conventional therapy with immunotherapy: A risky business?(2019)
Authors: An Coosemans, Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Michel Delforge, Ignace Vergote
Pages: 41 - 44